Story excerpt provided by Crain’s Cleveland Business.
Written by Timothy Magaw.
Juventas Therapeutics, a Cleveland-based clinical-stage company developing regenerative therapies for treatment of cardiovascular diseases, has secured $13.5 million in financing to support future clinical studies.
Click here to read the complete article.
Originally published May 12, 2015.